Veterinarian-founded cat healthcare company "uniam" raises 770 million yen in Series A funding. Full-scale launch of Japan's first cat longevity research institution and acceleration of recruitment.
NQ Score
100/100
AI Summary (NQ-processed)
Uniam, a cat-specialized healthcare brand founded by veterinarians, has successfully raised approximately 770 million yen in Series A funding. This investment will accelerate the launch of Japan's first cat longevity research institution and boost recruitment efforts. The company aims to establish itself as a 'cat health infrastructure' by expanding its preventive medicine-based food lines, publishing research papers, and entering overseas markets.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What company raised 770 million yen in Series A funding and what is its mission?
- A: uniam Inc. raised approximately 770 million yen in funding and operates with the mission of 'Love and Medicine for a Cat's Lifetime' to support cat health through preventive care.
- Q: Who were the lead investors and new shareholders in uniam's funding round?
- A: WPower Fund was the lead investor, and new shareholders included Crest Skill Partners and individual investors, alongside existing investor ANOBAKA Inc.
- Q: Which financial institutions provided loans to uniam Inc. as part of its funding?
- A: Japan Finance Corporation, Mizuho Bank, Hokkoku Bank, and Shoko Chukin Bank provided loans to uniam Inc. as part of its total funding package.
- Q: What is the size of the global pet care market and Japan's cat-related economy?
- A: The global pet care market is valued at approximately 31 trillion yen, while Japan's domestic cat-related economy has reached about 3 trillion yen.
- Q: How has the number of pet cats changed recently in the United States and China?
- A: In the US, cat-owning households increased by 23% year-on-year, and in China, the number of pet cats rose by approximately 1.76 times over the past five years.